Bley, I.A.; Behrens, S.; Spohn, M.; Müller, I.; Schattling, B.
Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma. J. Clin. Med. 2025, 14, 527.
https://doi.org/10.3390/jcm14020527
AMA Style
Bley IA, Behrens S, Spohn M, Müller I, Schattling B.
Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma. Journal of Clinical Medicine. 2025; 14(2):527.
https://doi.org/10.3390/jcm14020527
Chicago/Turabian Style
Bley, Isabelle Ariane, Stefan Behrens, Michael Spohn, Ingo Müller, and Benjamin Schattling.
2025. "Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma" Journal of Clinical Medicine 14, no. 2: 527.
https://doi.org/10.3390/jcm14020527
APA Style
Bley, I. A., Behrens, S., Spohn, M., Müller, I., & Schattling, B.
(2025). Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma. Journal of Clinical Medicine, 14(2), 527.
https://doi.org/10.3390/jcm14020527